Trial Profile
Association of serum IgG N-glycome and transforming growth factor-beta1 with hepatitis B virus e antigen seroconversion during entecavir therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 11 Dec 2015 New trial record